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“A New Method for Assessing Smoking Behavior in Orthopaedic Patients” 
 
Background: Tobacco use is associated with post-operative complications and self-reporting 
often introduces a bias that underestimates the true exposure. Traditional tobacco testing 
methods, including serum cotinine are associated with issues of specificity, as they do not 
differentiate active smokers from those on nicotine replacement therapies (NRTs). This study 
intends to evaluate the effectiveness of point-of-care carbon monoxide (CO) breathalyzer test 
to assess patient smoking status and to differentiate active smokers from those using NRTs. 
Methods: Eligible patients will be >18 years old and indicated for joint or fracture surgery at the 
Portland VA Orthopaedic clinic. Initially, patients will complete a self-reported smoking 
questionnaire, followed by CO testing with Smokerlyzer® Micro EC50 device and provision of 
serum cotinine labs. The primary outcome will be the sensitivity and specificity of the exhaled 
CO test relative to the current gold-standard test, serum cotinine levels. We will also perform a 
specific analysis using a subgroup of self-reported smokers and NRT-users (excluding non-
smokers) to evaluate the sensitivity and specificity of the CO test against self-reported smoking 
status. This will evaluate the test’s ability to differentiate between smokers and those on NRTs. 
Discussion: This study seeks to reduce the error of determining smoking status that is inherent 
in the current methods by assessing an alternative way to test smoking status in the clinic. This 
would provide necessary preliminary results to allow directly testing whether NRT use, separate 
from tobacco use, is associated with adverse outcomes following orthopaedic surgery.  
 
 
 
